Recipharm and Spektus team up to supply oral CNS drugs

22 January 2025

Spektus Pharma, a Quebec-based specialty pharma company developing therapeutics for the treatment of CNS disorders, has entered into a strategic partnership with Sweden-based contract development and manufacturing organization (CDMO) Recipharm.

The companies will jointly develop and supply a portfolio of CNS focused products in a partnership that will use Spektus’ Flexitab oral drug delivery platform to create flexible, breakable extended-release tablets for key global markets, including the USA, Canada, Europe, the UK and Brazil.

Spektus’ expertise in formulation development will be combined with Recipharm’s extensive manufacturing capabilities, regulatory excellence and robust global supply chain. 

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical